diasip® vanilla flavour combination liquid
pharmaworld store netherlands - 200 ml plastic bottle. - liquid - combination - nutrition , body fluids-compund multivitamin , mineral preparations
diasip® strawberry flavour combination liquid
pharmaworld store netherlands - 200 ml plastic bottle. - liquid - combination - nutrition , body fluids-compund multivitamin , mineral preparations
diasip® cappuccino flavour combination liquid
pharmaworld store netherlands - 200 ml plastic bottle. - liquid - combination - nutrition , body fluids-compund multivitamin , mineral preparations
diasip® cappuccino flavour
200 ml plastic bottle. -
diasip® strawberry flavour
200 ml plastic bottle. -
diasip® vanilla flavour
200 ml plastic bottle. -
candidiasis - yeast- adrenalinum, candida albicans thyroidinum, torula cerevisiae, triticum, ustilago maidis, antimon. crud., ar
newton laboratories, inc. - epinephrine (unii: ykh834o4bh) (epinephrine - unii:ykh834o4bh), candida albicans (unii: 4d7g21hdbc) (candida albicans - unii:4d7g21hdbc), thyroid, unspecified (unii: 0b4fdl9i6p) (thyroid, unspecified - unii:0b4fdl9i6p), saccharomyces cerevisiae (unii: 978d8u419h) (saccharomyces cerevisiae - unii:978d8u419h), elymus repens root (unii: 3ixw0f6p8w) (elymus repens root - unii:3ixw0f6p8w), ustilago maydis (unii: 4k7z7k7swg) (ustilago maydis - unii:4k7z7k7swg), antimony trisulfide (unii: f79059a38u) (antim - epinephrine 20 [hp_x] in 1 g - candida - yeast formulated for symptoms associated with vaginal yeast infections, oral thrush, esophogeal candidiasis, and other yeast or fungal overgrowth conditions. formulated for symptoms associated with vaginal yeast infections, oral thrush, esophogeal candidiasis, and other yeast or fungal overgrowth conditions.
candidiasis yeast- adrenalinum, candida albicans thyroidinum, torula cerevisiae, triticum, ustilago maidis, antimon. crud., arse
newton laboratories, inc. - epinephrine (unii: ykh834o4bh) (epinephrine - unii:ykh834o4bh), candida albicans (unii: 4d7g21hdbc) (candida albicans - unii:4d7g21hdbc), thyroid, unspecified (unii: 0b4fdl9i6p) (thyroid, unspecified - unii:0b4fdl9i6p), saccharomyces cerevisiae (unii: 978d8u419h) (saccharomyces cerevisiae - unii:978d8u419h), elymus repens top (unii: 8k1mk5e1fy) (elymus repens top - unii:8k1mk5e1fy), ustilago maydis (unii: 4k7z7k7swg) (ustilago maydis - unii:4k7z7k7swg), antimony trisulfide (unii: f79059a38u) (antimon - epinephrine 20 [hp_x] in 1 ml - candida~yeast formulated for symptoms associated with vaginal yeast infections, oral thrush, esophogeal candidiasis, and other yeast or fungal overgrowth conditions. formulated for symptoms associated with vaginal yeast infections, oral thrush, esophogeal candidiasis, and other yeast or fungal overgrowth conditions.
candidiasis - yeast- adrenalinum, candida albicans, thyroidinum, torula cerevisiae, triticum, ustilago maidis, antimon. crud, ar
newton laboratories, inc. - nitric acid (unii: 411vrn1tv4) (nitric acid - unii:411vrn1tv4), phosphorus (unii: 27ylu75u4w) (phosphorus - unii:27ylu75u4w), podophyllum (unii: 2s713a4vp3) (podophyllum - unii:2s713a4vp3), anemone pulsatilla (unii: i76kb35jev) (anemone pulsatilla - unii:i76kb35jev), sepia officinalis juice (unii: qdl83wn8c2) (sepia officinalis juice - unii:qdl83wn8c2), echinacea, unspecified (unii: 4n9p6cc1dx) (echinacea, unspecified - unii:4n9p6cc1dx), ginkgo (unii: 19fuj2c58t) (ginkgo - unii:19fuj2c58t), juglans r - formulated for symptoms such as vaginal itching or discharge, mental fogginess, fatigue, gas and bloating. formulated for symptoms such as vaginal itching or discharge, mental fogginess, fatigue, gas and bloating.
cancidas (previously caspofungin msd)
merck sharp & dohme b.v. - caspofungin (as acetate) - candidiasis; aspergillosis - antimycotics for systemic use - treatment of invasive candidiasis in adult or paediatric patients;treatment of invasive aspergillosis in adult or paediatric patients who are refractory to or intolerant of amphotericin b, lipid formulations of amphotericin b and / or itraconazole. refractoriness is defined as progression of infection or failure to improve after a minimum of seven days of prior therapeutic doses of effective antifungal therapy;empirical therapy for presumed fungal infections (such as candida or aspergillus) in febrile, neutropaenic adult or paediatric patients.